Socioeconomic factors, urological epidemiology and practice patterns

Comment

David F Penson et al. J Urol. 2010 Nov.

. 2010 Nov;184(5):1991-4.

doi: 10.1016/j.juro.2010.07.024. Epub 2010 Sep 19.

No abstract available

Comment on

Race, healthcare access and physician trust among prostate cancer patients.
Do YK, Carpenter WR, Spain P, Clark JA, Hamilton RJ, Galanko JA, Jackman A, Talcott JA, Godley PA. Do YK, et al. Cancer Causes Control. 2010 Jan;21(1):31-40. doi: 10.1007/s10552-009-9431-y. Epub 2009 Sep 24. Cancer Causes Control. 2010. PMID: 19777359 Free PMC article.
Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.
Talcott JA, Rossi C, Shipley WU, Clark JA, Slater JD, Niemierko A, Zietman AL. Talcott JA, et al. JAMA. 2010 Mar 17;303(11):1046-53. doi: 10.1001/jama.2010.287. JAMA. 2010. PMID: 20233822
Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare.
Bynum J, Song Y, Fisher E. Bynum J, et al. J Am Geriatr Soc. 2010 Apr;58(4):674-80. doi: 10.1111/j.1532-5415.2010.02761.x. Epub 2010 Mar 22. J Am Geriatr Soc. 2010. PMID: 20345867 Free PMC article.
Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer.
Ito K, Elkin EB, Girotra M, Morris MJ. Ito K, et al. Ann Intern Med. 2010 May 18;152(10):621-9. doi: 10.7326/0003-4819-152-10-201005180-00002. Ann Intern Med. 2010. PMID: 20479027 Free PMC article.